» Articles » PMID: 18213585

Muscleblind-like 2 (Mbnl2) -deficient Mice As a Model for Myotonic Dystrophy

Overview
Journal Dev Dyn
Publisher Wiley
Date 2008 Jan 24
PMID 18213585
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Myotonic dystrophy (DM), the most common adult-onset muscular dystrophy, is caused by CTG or CCTG microsatellite repeat expansions. Expanded DM mRNA microsatellite repeats are thought to accumulate in the nucleus, sequester Muscleblind proteins, and interfere with alternative mRNA splicing. Muscleblind2 (Mbnl2) is a member of the family of Muscleblind RNA binding proteins (that also include Mbnl1 and Mbnl3) that are known to bind CTG/CCTG RNA repeats. Recently, it was demonstrated that Mbnl1-deficient mice have characteristic features of human DM, including myotonia and defective chloride channel expression. Here, we demonstrate that Mbnl2-deficient mice also develop myotonia and have skeletal muscle pathology consistent with human DM. We also find defective expression and mRNA splicing of the chloride channel (Clcn1) in skeletal muscle that likely contributes to the myotonia phenotype. Our results support the hypothesis that Muscleblind proteins and specifically MBNL2 contribute to the pathogenesis of human DM.

Citing Articles

Genome-wide identification of antisense lncRNAs and their association with susceptibility to in rainbow trout.

Ali A, Salem M Front Immunol. 2022; 13:1050722.

PMID: 36561762 PMC: 9763276. DOI: 10.3389/fimmu.2022.1050722.


RNA-binding Protein MBNL2 regulates Cancer Cell Metastasis through MiR-182-MBNL2-AKT Pathway.

Lin G, Li J, Cai J, Zhang H, Xin Q, Wang N J Cancer. 2021; 12(22):6715-6726.

PMID: 34659561 PMC: 8518006. DOI: 10.7150/jca.62816.


From Mice to Humans: An Overview of the Potentials and Limitations of Current Transgenic Mouse Models of Major Muscular Dystrophies and Congenital Myopathies.

Sztretye M, Szabo L, Dobrosi N, Fodor J, Szentesi P, Almassy J Int J Mol Sci. 2020; 21(23).

PMID: 33255644 PMC: 7728138. DOI: 10.3390/ijms21238935.


Resveratrol corrects aberrant splicing of pre-mRNA and Ca signal in myotonic dystrophy type 1 myotubes.

Santoro M, Piacentini R, Perna A, Pisano E, Severino A, Modoni A Neural Regen Res. 2020; 15(9):1757-1766.

PMID: 32209783 PMC: 7437583. DOI: 10.4103/1673-5374.276336.


Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1.

Yin Q, Wang H, Li N, Ding Y, Xie Z, Jin L Cell Res. 2019; 30(2):133-145.

PMID: 31853004 PMC: 7015062. DOI: 10.1038/s41422-019-0264-2.